Enjoy complimentary customisation on priority with our Enterprise License!
The cardiovascular therapeutics market size is forecast to increase by USD 24.25 million at a CAGR of 4.57% between 2023 and 2028. The market is experiencing significant growth due to the rising prevalence of cardiovascular diseases (CVDs) driven by increasing risk factors such as obesity, diabetes, and sedentary lifestyles. A key trend in the market is the advent of novel oral anticoagulants (NOACs), which offer advantages over traditional anticoagulants in terms of safety, efficacy, and convenience. Another trend is the emergence of wearable defibrillators, which enable early detection and intervention for life-threatening cardiac conditions. The market faces challenges including regulatory requirements, high development costs, and competition from generic drugs. Despite these challenges, the market is expected to continue its growth trajectory due to the unmet medical need for effective and innovative cardiovascular therapies.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.